AP HDD 2-c
EN_00962895_4558
FILE --- The headquarters of Swiss chemicals group Lonza in Basel, Switzerland, is seen in this November 26, 1999 file picture. Lonza announced on Tuesday, October 24, 2006, that it buys two units from the United States drugs maker Cambrex Corp for $ 460 million (Euro 366 million). The deal to purchase the units, Research Bioproducts and Microbial Biopharmaceutical, will strengthen Lonza's biopharmaceutical business. (KEYSTONE/Markus Stuecklin)
DATABASE
Minimum price 50PLN
1999-01-02
KEY/East News
Associated Press
MARKUS STUECKLIN
9901020777
1,09MB
13cm x 20cm przy 300dpi
1999, 2006, 24, 26, 366, 460, AND, ANNOUNCED, BASEL, BIOPHARMACEUTICAL, BIOPRODUCTS, BUSINESS, BUYS, CAMBREX, CHEMICALS, CORP, DEAL, DRUGS, EURO, FILE, FOR, FROM, GROUP, HEADQUARTERS, IN, IS, IT, KEYSTONE, LONZA, MAKER, MARKUS, MICROBIAL, MILLION, NOVEMBER, OCTOBER, OF, ON, PICTURE, PURCHASE, RESEARCH, SEEN, STATES, STRENGTHEN, STUECKLIN, SWISS, SWITZERLAND, THAT, THE, THIS, TO, TUESDAY, TWO, UNITED, UNITS, WILL,